|
G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]
|
CTD |
PMID:35101544 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
G
|
Acat1
|
acetyl-CoA acetyltransferase 1
|
decreases expression
|
ISO
|
cryptotanshinone results in decreased expression of ACAT1 mRNA
|
CTD |
PMID:38936533 |
|
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042
|
|
G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
ISO
|
cryptotanshinone binds to and results in decreased activity of ACHE protein
|
CTD |
PMID:20350537 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
decreases expression multiple interactions
|
ISO
|
cryptotanshinone results in decreased expression of ACTA2 mRNA; cryptotanshinone results in decreased expression of ACTA2 protein cryptotanshinone inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; cryptotanshinone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of ACTA2 mRNA]; CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of ACTA2 protein]
|
CTD |
PMID:38936533 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
cryptotanshinone promotes the reaction [beta-Naphthoflavone results in increased expression of AHR mRNA]
|
CTD |
PMID:21262253 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
ISO
|
cryptotanshinone binds to and results in decreased activity of BCHE protein
|
CTD |
PMID:20350537 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
G
|
Casp3
|
caspase 3
|
increases cleavage multiple interactions increases activity
|
ISO
|
cryptotanshinone results in increased cleavage of CASP3 protein benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [cryptotanshinone results in increased cleavage of CASP3 protein] cryptotanshinone results in increased activity of CASP3 protein
|
CTD |
PMID:26564229 PMID:28600121 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp7
|
caspase 7
|
increases activity
|
ISO
|
cryptotanshinone results in increased activity of CASP7 protein
|
CTD |
PMID:26564229 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
G
|
Casp9
|
caspase 9
|
increases activity
|
ISO
|
cryptotanshinone results in increased activity of CASP9 protein
|
CTD |
PMID:26564229 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in decreased expression of CDH1 protein]
|
CTD |
PMID:30208247 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
multiple interactions decreases expression
|
ISO
|
CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of COL1A1 mRNA]; CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of COL1A1 protein] cryptotanshinone inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 protein]; cryptotanshinone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] cryptotanshinone results in decreased expression of COL1A1 mRNA; cryptotanshinone results in decreased expression of COL1A1 protein
|
CTD |
PMID:38936533 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions decreases expression
|
ISO
|
CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of ACTA2 mRNA]; CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of ACTA2 protein]; CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of COL1A1 mRNA]; CPT1A protein inhibits the reaction [cryptotanshinone results in decreased expression of COL1A1 protein] cryptotanshinone results in decreased expression of CPT1A mRNA; cryptotanshinone results in decreased expression of CPT1A protein
|
CTD |
PMID:38936533 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
G
|
Cpt1b
|
carnitine palmitoyltransferase 1B
|
decreases expression
|
ISO
|
cryptotanshinone results in decreased expression of CPT1B mRNA
|
CTD |
PMID:38936533 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
|
|
G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of CTNNB1 protein]
|
CTD |
PMID:30208247 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions increases expression
|
ISO
|
cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A1 mRNA] cryptotanshinone results in increased expression of CYP1A1 mRNA; cryptotanshinone results in increased expression of CYP1A1 protein
|
CTD |
PMID:21262253 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases expression multiple interactions
|
ISO
|
cryptotanshinone results in increased expression of CYP1A2 mRNA; cryptotanshinone results in increased expression of CYP1A2 protein cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]; Resveratrol inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA]
|
CTD |
PMID:21262253 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases expression
|
ISO
|
cryptotanshinone results in increased expression of CYP3A4 protein
|
CTD |
PMID:18805405 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of EGFR protein modified form]
|
CTD |
PMID:30208247 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; cryptotanshinone inhibits the reaction [Lithocholic Acid results in increased expression of GPT protein]
|
CTD |
PMID:36804361 PMID:38936533 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in decreased expression of GSK3B protein]
|
CTD |
PMID:30208247 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
G
|
Jak2
|
Janus kinase 2
|
decreases phosphorylation
|
ISO
|
cryptotanshinone results in decreased phosphorylation of JAK2 protein
|
CTD |
PMID:38936533 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions increases expression
|
ISO
|
Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog promotes the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein]; cryptotanshinone promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein]
|
CTD |
PMID:28600121 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [notoginsenoside R1 results in increased expression of MCL1 protein]
|
CTD |
PMID:38316350 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cryptotanshinone results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone results in increased degradation of and results in increased phosphorylation of NFKBIA protein]; cryptotanshinone results in increased degradation of and results in increased phosphorylation of NFKBIA protein
|
CTD |
PMID:28600121 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity
|
ISO
|
cryptotanshinone results in increased activity of NR1I2 protein
|
CTD |
PMID:18805405 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
cryptotanshinone results in increased cleavage of PARP1 protein
|
CTD |
PMID:26564229 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Ptger2
|
prostaglandin E receptor 2
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of PTGER2 protein]
|
CTD |
PMID:30208247 |
|
NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950
|
|
G
|
Ptger4
|
prostaglandin E receptor 4
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of PTGER4 protein]
|
CTD |
PMID:30208247 |
|
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135
|
|
G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
decreases activity
|
ISO
|
cryptotanshinone results in decreased activity of PTPN1 protein
|
CTD |
PMID:29031618 |
|
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
G
|
Rarb
|
retinoic acid receptor, beta
|
increases expression
|
ISO
|
cryptotanshinone results in increased expression of RARB protein
|
CTD |
PMID:38936533 |
|
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions affects localization
|
ISO
|
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cryptotanshinone affects the localization of RELA protein]; Acetylcysteine inhibits the reaction [cryptotanshinone affects the localization of RELA protein]; cryptotanshinone inhibits the reaction [TNF protein affects the localization of RELA protein]
|
CTD |
PMID:26564229 PMID:28600121 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
increases expression
|
ISO
|
cryptotanshinone results in increased expression of RXRA protein
|
CTD |
PMID:38936533 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
G
|
Sqstm1
|
sequestosome 1
|
multiple interactions decreases expression
|
ISO
|
Chloroquine inhibits the reaction [cryptotanshinone results in decreased expression of SQSTM1 protein]
|
CTD |
PMID:28600121 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
decreases phosphorylation multiple interactions
|
ISO
|
cryptotanshinone results in decreased phosphorylation of STAT3 protein cryptotanshinone results in decreased phosphorylation of and affects the localization of STAT3 protein cryptotanshinone inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:28578322 PMID:38936533 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; cryptotanshinone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
|
CTD |
PMID:38936533 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
cryptotanshinone inhibits the reaction [TNF protein affects the localization of RELA protein]
|
CTD |
PMID:26564229 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Top2a
|
DNA topoisomerase II alpha
|
decreases expression multiple interactions
|
ISO
|
cryptotanshinone results in decreased expression of TOP2A mRNA cryptotanshinone results in decreased expression of and results in decreased activity of TOP2A protein
|
CTD |
PMID:28716507 |
|
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
|
|
G
|
Top2b
|
DNA topoisomerase II beta
|
decreases expression
|
ISO
|
cryptotanshinone results in decreased expression of TOP2B mRNA
|
CTD |
PMID:28716507 |
|
NCBI chr15:11,482,089...11,542,464
Ensembl chr15:11,482,089...11,542,464
|
|